These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8763871)

  • 1. Tumour blood flow modification by endothelin-related peptides in the rat HSN fibrosarcoma.
    Bell KM; Prise VE; Chaplin DJ; Tozer GM
    Br J Cancer Suppl; 1996 Jul; 27():S161-3. PubMed ID: 8763871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of endothelin-1 and sarafotoxin S6c on blood flow in a rat tumor.
    Bell KM; Prise VE; Chaplin DJ; Tozer GM
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S222-5. PubMed ID: 8587370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of tumour blood flow modification in two rat tumour systems using endothelin-1 and angiotensin II: influence of tumour size on angiotensin II response.
    Bell KM; Prise VE; Shaffi KM; Chaplin DJ; Tozer GM
    Int J Cancer; 1996 Sep; 67(5):730-8. PubMed ID: 8782666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of blood flow in the HSN tumour and normal tissues of the rat by the endothelin ET(B) receptor agonist, IRL 1620.
    Bell KM; Chaplin DJ; Poole BA; Prise VE; Tozer GM
    Int J Cancer; 1999 Jan; 80(2):295-302. PubMed ID: 9935213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular response of tumour and normal tissues to endothelin-1 following antagonism of ET(A) and ET(B) receptors in anaesthetised rats.
    Bell KM; Prise VE; Chaplin DJ; Wordsworth S; Tozer GM
    Int J Cancer; 1997 Oct; 73(2):283-9. PubMed ID: 9335456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the contractile effects and binding kinetics of endothelin-1 and sarafotoxin S6b in rat isolated renal artery.
    Devadason PS; Henry PJ
    Br J Pharmacol; 1997 May; 121(2):253-63. PubMed ID: 9154335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distinct alterations produced in cardiovascular functions by prednisolone and nitro-prednisolone (NCX-1015) in the rat highlight a causal role for endothelin-1.
    Di Filippo C; Rossi F; Ongini E; Del Soldato P; Perretti M; D'Amico M
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1133-41. PubMed ID: 15113846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sarafotoxin S6c on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs.
    Matsuo G; Matsumura Y; Tadano K; Morimoto S
    J Pharmacol Exp Ther; 1997 Feb; 280(2):905-10. PubMed ID: 9023305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1-induced pulmonary vasoreactivity is regulated by ET(A) and ET(B) receptor interactions.
    Sauvageau S; Thorin E; Caron A; Dupuis J
    J Vasc Res; 2007; 44(5):375-81. PubMed ID: 17495482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine.
    Tozer GM; Prise VE; Chaplin DJ
    Cancer Res; 1997 Mar; 57(5):948-55. PubMed ID: 9041200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin receptors in lower esophageal sphincter circular smooth muscle.
    Huang SC
    Regul Pept; 2005 Apr; 127(1-3):27-35. PubMed ID: 15680467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1-induced circulatory response in the rat: the role of ETA and ETB receptors.
    Szalay L; Boros M; Baranyi L; Okada H; Nagy S
    Acta Chir Hung; 1997; 36(1-4):340-2. PubMed ID: 9408395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-selective antivascular effects of the novel anti-mitotic compound A-318315: An in vivo rat regional haemodynamic study.
    Segreti JA; Brooks KA; Marsh KC; Bauch JL; Lan Y; Thomas Lin C; Rosenberg SH; Sham HL; Reinhart GA; Cox BF; Polakowski JS
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):636-40. PubMed ID: 20132238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification.
    Cemazar M; Wilson I; Prise VE; Bell KM; Hill SA; Tozer GM
    Br J Cancer; 2005 Jul; 93(1):98-106. PubMed ID: 15970923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of centrally administered endothelin agonists on systemic and regional blood circulation in the rat: role of sympathetic nervous system.
    Gulati A; Kumar A; Morrison S; Shahani BT
    Neuropeptides; 1997 Aug; 31(4):301-9. PubMed ID: 9308015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic responses to sarafotoxin 6 peptides.
    Minkes RK; Kadowitz PJ
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S293-6. PubMed ID: 1725360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of two prostaglandin synthesis inhibitors on the intratumor distribution of blood flow and vascular volume in a transplantable rat fibrosarcoma.
    Karlsson L; Alpsten M; Peterson HI
    Anticancer Res; 1984; 4(3):125-8. PubMed ID: 6465850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial heterogeneity of tumour blood flow modification induced by angiotensin II: relationship to receptor distribution.
    Tozer GM; Shaffi KM; Prise VE; Bell KM
    Int J Cancer; 1996 Mar; 65(5):658-63. PubMed ID: 8598318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of erythrocyte transfusion on the circulation of Guérin carcinoma-bearing rats.
    Takács L; Albert K; Karai A; Szarvassy I
    Acta Physiol Hung; 1984; 64(1):9-17. PubMed ID: 6485821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of tumour blood flow using the hypertensive agent, angiotensin II.
    Tozer GM; Shaffi KM
    Br J Cancer; 1993 May; 67(5):981-8. PubMed ID: 8494732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.